Arbutus Biopharma (0SGC.LSE) Q4 2023 Earnings

Feb 29Confirmed
Q4 2023
-0.12
-0.12
-0.12
-0.12

Details

Expected EPS
-0.116
Actual EPS
-0.12
Surprise EPS
-0
Surprise Percent
-3.45%

Description

⁨Arbutus Biopharma⁩ (⁦0SGC.LSE⁩) has reported earnings of ⁦-0.12⁩ per share for ⁦Q4 2023⁩.

0 Comments

Share your thoughts